Panzenbeck M, Baez A, Kaley G
J Pharmacol Exp Ther. 1986 May;237(2):525-8.
The authors studied the effects of bolus injections of hydralazine (500 micrograms) into the renal artery of chloralose-anesthetized dogs. In control dogs, hydralazine injection resulted in an increase in renal artery blood flow of 110 +/- 10.4 ml/min (53 +/- 4.7%) from 214 +/- 28 ml/min. In dogs that were pretreated with the alpha-1 adrenergic antagonist, prazosin (1 mg/kg), hydralazine injection increased renal blood flow by 95 +/- 22 ml/min (37 +/- 7.4%) from 253 +/- 19 ml/min, an increase not different from that found in control dogs. However, in dogs pretreated with indomethacin (5 mg/kg) or sodium meclofenamate (3 mg/kg), inhibitors of cyclooxygenase, hydralazine injection resulted in an increase in renal artery blood flow of only 44 +/- 5.3 ml/min (19 +/- 2.7%) from 235 +/- 23 ml/min, an increase significantly different from that in control dogs (P less than .05). The renal blood flow response to hydralazine injection developed slowly, reached a maximum in 20 min and was maintained for at least 1 hr. Arterial blood pressure, heart rate and descending aortic blood flow were not significantly changed after hydralazine injection. The authors conclude that hydralazine increases renal blood flow in dogs by a mechanism independent of alpha-1 adrenergic receptors and that this increase is, in large part, mediated by prostaglandin release.
作者研究了向水合氯醛麻醉的犬肾动脉内一次性注射肼屈嗪(500微克)的效果。在对照犬中,注射肼屈嗪后肾动脉血流量从214±28毫升/分钟增加到110±10.4毫升/分钟(增加了53±4.7%)。在预先用α-1肾上腺素能拮抗剂哌唑嗪(1毫克/千克)处理的犬中,注射肼屈嗪使肾血流量从253±19毫升/分钟增加了95±22毫升/分钟(增加了37±7.4%),这一增加与对照犬中观察到的增加无差异。然而,在预先用环氧化酶抑制剂吲哚美辛(5毫克/千克)或甲氯芬那酸钠(3毫克/千克)处理的犬中,注射肼屈嗪后肾动脉血流量仅从235±23毫升/分钟增加了44±5.3毫升/分钟(增加了19±2.7%),这一增加与对照犬中的增加有显著差异(P<0.05)。肼屈嗪注射后肾血流量的反应发展缓慢,在20分钟时达到最大值,并维持至少1小时。注射肼屈嗪后动脉血压、心率和降主动脉血流量无显著变化。作者得出结论,肼屈嗪通过一种不依赖于α-1肾上腺素能受体的机制增加犬的肾血流量,并且这种增加在很大程度上是由前列腺素释放介导的。